Mesa Historical Income Statement
| MLAB Stock | USD 100.86 2.27 2.30% |
Historical analysis of Mesa Laboratories income statement accounts such as Other Operating Expenses of 512.7 M can show how well Mesa Laboratories performed in making a profits. Evaluating Mesa Laboratories income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Mesa Laboratories's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Mesa Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mesa Laboratories is a good buy for the upcoming year.
Mesa |
About Mesa Income Statement Analysis
Mesa Laboratories Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Mesa Laboratories shareholders. The income statement also shows Mesa investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Mesa Laboratories Income Statement Chart
Add Fundamental
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Mesa Laboratories minus its cost of goods sold. It is profit before Mesa Laboratories operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Mesa Laboratories. It is also known as Mesa Laboratories overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Mesa Laboratories income statement and represents the costs associated with goods and services Mesa Laboratories provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Net Income Applicable To Common Shares
The net income that remains after preferred dividends have been deducted, available to common shareholders.Most accounts from Mesa Laboratories' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Mesa Laboratories current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesa Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.At present, Mesa Laboratories' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 227 M, whereas Operating Income is projected to grow to (258.5 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 109.1M | 133.7M | 133.3M | 139.9M | Total Revenue | 184.3M | 219.1M | 216.2M | 227.0M |
Mesa Laboratories income statement Correlations
Click cells to compare fundamentals
Mesa Laboratories Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Mesa Laboratories income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 5.5M | 8.0M | 3.9M | 3.7M | 5.7M | 6.0M | |
| Total Revenue | 117.7M | 133.9M | 184.3M | 219.1M | 216.2M | 227.0M | |
| Gross Profit | 64.9M | 87.0M | 109.1M | 133.7M | 133.3M | 139.9M | |
| Other Operating Expenses | 109.9M | 121.6M | 179.6M | 215.8M | 488.3M | 512.7M | |
| Cost Of Revenue | 52.8M | 46.9M | 75.2M | 85.4M | 82.9M | 87.1M | |
| Total Operating Expenses | 57.1M | 74.7M | 104.4M | 130.4M | 406.6M | 426.9M | |
| Operating Income | (4.9M) | (5.3M) | (20.4M) | (30.5M) | (272.1M) | (258.5M) | |
| Ebit | (4.9M) | (5.1M) | 4.7M | 3.3M | (270.0M) | (256.5M) | |
| Ebitda | 8.1M | 12.4M | 29.8M | 36.5M | (238.4M) | (226.5M) | |
| Income Before Tax | 3.4M | 2.3M | 3.6M | (389K) | (275.6M) | (261.9M) | |
| Total Other Income Expense Net | 8.3M | (10.1M) | (1.1M) | (3.7M) | (3.6M) | (3.4M) | |
| Net Income | 1.3M | 3.3M | 1.9M | 930K | (254.2M) | (241.5M) | |
| Income Tax Expense | 2.1M | (971K) | 1.7M | (1.3M) | (21.4M) | (20.3M) | |
| Depreciation And Amortization | 13.0M | 17.5M | 25.1M | 33.1M | 31.6M | 33.2M | |
| Research Development | 6.4M | 10.4M | 15.8M | 20.5M | 19.3M | 20.3M | |
| Selling General Administrative | 37.8M | 45.7M | 60.3M | 72.4M | 72.9M | 76.5M | |
| Net Income Applicable To Common Shares | 1.3M | 3.3M | 1.9M | 930K | 1.1M | 1.0M | |
| Selling And Marketing Expenses | 12.9M | 18.5M | 28.3M | 37.4M | 38.6M | 36.7M | |
| Net Income From Continuing Ops | 1.3M | 3.3M | 1.9M | 930K | (254.2M) | (241.5M) | |
| Non Operating Income Net Other | (1.2M) | 1.4M | (2.0M) | 1.1M | 954.9K | 1.0M | |
| Tax Provision | 2.1M | (971K) | 1.7M | (1.3M) | (21.4M) | (20.3M) | |
| Reconciled Depreciation | 13.0M | 17.7M | 25.1M | 33.8M | 31.6M | 22.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mesa Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesa Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesa Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesa Laboratories Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesa Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. If investors know Mesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesa Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.875 | Dividend Share 0.64 | Earnings Share (45.62) | Revenue Per Share 42.3 | Quarterly Revenue Growth 0.088 |
The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesa Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesa Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesa Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.